
Researchers at the University of Edinburgh have identified a distinct hormone profile associated with endometriosis that could lead to the …

The International Accrediting Organization for Clinical Research (IAOCR) has partnered with MARC to support the adoption of international clinical research …

Cyllene Therapeutics has raised €33m in Series C financing to support later-stage development of EG110A, an investigational genetic medicine for …

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Probi is marking its 35th anniversary alongside a milestone of more than 300 scientific publications supporting the benefits of its …

Telum Therapeutics has raised €18m in Series A financing to advance its lead antimicrobial programme into phase 1 clinical development …

Mallia Innovations has raised €3m to support the European expansion of its hormone-free hair growth products and prepare for potential …

Celerion has expanded its bioanalytical laboratory in Zurich, Switzerland, to increase capacity for drug development programmes and support growing global …

Vedana Therapeutics has emerged from stealth with $46m in Series A financing to support development of a pipeline of investigational …

Kither Biotech has reported positive results from a phase 1 study of KIT2014, an investigational inhaled therapy being developed for …

PL BioScience has announced the appointment of Maik Jornitz to its board of directors, effective immediately. Jornitz brings technical expertise, …

Axplora has announced the consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag facility in India as part of a …

New data from the PIONEER study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 suggest …

Sandoz has opened a new biosimilar development centre in Ljubljana, Slovenia, as part of efforts to expand its in-house capabilities …

Codis has announced three strategic appointments within its Business Development function. Pedro Fernandes Botas has been appointed as Business Development …

UK based Cizzle Biotechnology has announced that its CIZ1B lung cancer blood test has been approved for use under Clinical …

Researchers at Northumbria University are leading a £1.3m study aimed at helping GP practices improve care for young adults living …

Gesynta Pharma has announced that 50% of the target enrolment has been reached in its phase 2 NOVA trial evaluating …

NICE has issued Final Draft Guidance recommending AbbVie’s AQUIPTA (atogepant) as an option for the acute treatment of migraine, with …

New survey data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress suggest many people at risk …